Time to initial glycopeptide therapy and 30-day mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
Abstract Background The optimal time cut-off for appropriate antibiotic therapy (AAT) in methicillin-resistant Staphylococcus aureus (MRSA) bacteremia remains uncertain. We assessed the effects of time to AAT on 30-day in-hospital mortality in patients with MRSA bacteremia who received glycopeptides...
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2025-11-01
|
| סדרה: | BMC Infectious Diseases |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12879-025-12040-9 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|